Uterine sarcoma is rare (3–7 per 100,000 in the US population) with a poor prognosis. Leiomyosarcomas are the most common of the uterine sarcomas. A US FDA report estimated the prevalence of ...

As with uterine sarcoma, endometrial carcinoma (EC) usually affects the upper part (or body) of the uterus. EC can be classified by the type of cell that they originate from, with endometrial ...

When Roberta Garau’s mother died from a rare cancer ten years ago, her daughter promised that she would help people like her ...

Let’s explore how science and diet are becoming the twin pillars of our future health(1 Trusted Source Investigating the Use of Circulating Tumor DNA for Sarcoma Management Go to source).

A supervised exercise already shown to alleviate fatigue and other side effects in patients with metastatic breast cancer has now been found to also be cost analysis. Anne May, PhD, of Utrecht ...

In 2017, Suni Elgar, MPH, RN, hadn’t yet become associate chief nursing officer at Fred Hutch Cancer Center, but change was coming. Her supervisor, Rosemary Ford, BSN, RN, was wrapping up a 40-year ...

The pathway Helena Ochoa followed to her current job as a scientist at Pfizer started in a learning lab at Fred Hutch Cancer Center. Ochoa first came to Fred Hutch on a high school field trip with her ...

A sarcoma is a cancer that arises from uncontrolled cell growth in tissues of mesodermal origins, such as connective tissue, bone, cartilage, fat or muscle. There are around 100 different subtypes ...

State Sen. Barbara Favola, who represents the majority of Arlington County, is undergoing treatment for uterine cancer. In a social media post today (Monday), the 69-year-old said she successfully ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

an open-label trial that is evaluating GSK'227 in patients with relapsed or refractory osteosarcoma and other unresectable bone and soft tissue sarcomas, which is being conducted by Hansoh in China.